Published in J Neurosci on February 22, 2012
Ca(2+)/calmodulin-dependent protein kinase IIα (αCaMKII) controls the activity of the dopamine transporter: implications for Angelman syndrome. J Biol Chem (2012) 1.14
You are what you eat: influence of type and amount of food consumed on central dopamine systems and the behavioral effects of direct- and indirect-acting dopamine receptor agonists. Neuropharmacology (2012) 1.04
SLC6A3 coding variant Ala559Val found in two autism probands alters dopamine transporter function and trafficking. Transl Psychiatry (2014) 1.00
Eating high fat chow decreases dopamine clearance in adolescent and adult male rats but selectively enhances the locomotor stimulating effects of cocaine in adolescents. Int J Neuropsychopharmacol (2015) 0.90
Dopamine receptors - IUPHAR Review 13. Br J Pharmacol (2015) 0.87
Enhanced nicotine self-administration and suppressed dopaminergic systems in a rat model of diabetes. Addict Biol (2013) 0.83
mTORC2/rictor signaling disrupts dopamine-dependent behaviors via defects in striatal dopamine neurotransmission. J Neurosci (2015) 0.81
Modulation of Food Reward by Endocrine and Environmental Factors: Update and Perspective. Psychosom Med (2015) 0.80
Moving beyond energy homeostasis: new roles for glucagon-like peptide-1 in food and drug reward. Neurochem Int (2013) 0.79
Kinase-dependent Regulation of Monoamine Neurotransmitter Transporters. Pharmacol Rev (2016) 0.78
Reduced insulin sensitivity is related to less endogenous dopamine at D2/3 receptors in the ventral striatum of healthy nonobese humans. Int J Neuropsychopharmacol (2015) 0.78
Increased dopamine transporter function as a mechanism for dopamine hypoactivity in the adult infralimbic medial prefrontal cortex following adolescent social stress. Neuropharmacology (2015) 0.76
Glucagon-like peptide 1 receptor activation regulates cocaine actions and dopamine homeostasis in the lateral septum by decreasing arachidonic acid levels. Transl Psychiatry (2016) 0.75
High fat diet augments amphetamine sensitization in mice: Role of feeding pattern, obesity, and dopamine terminal changes. Neuropharmacology (2016) 0.75
Dietary supplementation with fish oil prevents high fat diet-induced enhancement of sensitivity to the locomotor stimulating effects of cocaine in adolescent female rats. Drug Alcohol Depend (2016) 0.75
The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res (2001) 6.59
Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum. Proc Natl Acad Sci U S A (2004) 3.87
IRS2-Akt pathway in midbrain dopamine neurons regulates behavioral and cellular responses to opiates. Nat Neurosci (2006) 2.71
Is dopamine a physiologically relevant mediator of feeding behavior? Trends Neurosci (2007) 2.59
D2 receptors regulate dopamine transporter function via an extracellular signal-regulated kinases 1 and 2-dependent and phosphoinositide 3 kinase-independent mechanism. Mol Pharmacol (2007) 2.28
Dopamine signaling in the dorsal striatum is essential for motivated behaviors: lessons from dopamine-deficient mice. Ann N Y Acad Sci (2008) 2.15
Insulin, leptin, and food reward: update 2008. Am J Physiol Regul Integr Comp Physiol (2008) 1.84
Modulation of food reward by adiposity signals. Physiol Behav (2006) 1.65
PI 3-kinase regulation of dopamine uptake. J Neurochem (2002) 1.64
Mitogen-activated protein kinase regulates dopamine transporter surface expression and dopamine transport capacity. J Neurosci (2003) 1.63
Detection of dopaminergic neurotransmitter activity using pharmacologic MRI: correlation with PET, microdialysis, and behavioral data. Magn Reson Med (1997) 1.56
Hypoinsulinemia regulates amphetamine-induced reverse transport of dopamine. PLoS Biol (2007) 1.48
Akt is essential for insulin modulation of amphetamine-induced human dopamine transporter cell-surface redistribution. Mol Pharmacol (2005) 1.47
Effect of acute hyperglycemia on visual cortical activation as measured by functional MRI. J Neurosci Res (2000) 1.45
Dopamine transporter cell surface localization facilitated by a direct interaction with the dopamine D2 receptor. EMBO J (2007) 1.44
Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum. J Neurochem (1999) 1.43
Deficits in dopamine clearance and locomotion in hypoinsulinemic rats unmask novel modulation of dopamine transporters by amphetamine. J Neurochem (2005) 1.34
Dopamine transporter activity mediates amphetamine-induced inhibition of Akt through a Ca2+/calmodulin-dependent kinase II-dependent mechanism. Mol Pharmacol (2006) 1.27
In vivo dopamine clearance rate in rat striatum: regulation by extracellular dopamine concentration and dopamine transporter inhibitors. J Pharmacol Exp Ther (1999) 1.26
Food deprivation decreases mRNA and activity of the rat dopamine transporter. Neuroendocrinology (1998) 1.24
Direct in vivo evidence that D2 dopamine receptors can modulate dopamine uptake. Neurosci Lett (1994) 1.19
Regulation of dopamine transporter function and cell surface expression by D3 dopamine receptors. J Biol Chem (2007) 1.19
D2 receptors may modulate the function of the striatal transporter for dopamine: kinetic evidence from studies in vitro and in vivo. J Neurochem (1993) 1.17
Neural plasticity and addiction: PI3-kinase and cocaine behavioral sensitization. Nat Neurosci (2002) 1.11
Brief, repeated exposure to substrates down-regulates dopamine transporter function in Xenopus oocytes in vitro and rat dorsal striatum in vivo. J Neurochem (2002) 1.10
Insulin signaling and addiction. Neuropharmacology (2011) 1.04
Contributions of ERK signaling in the striatum to instrumental learning and performance. Behav Brain Res (2010) 1.03
Extracellular signal-regulated mitogen-activated protein kinase inhibitors decrease amphetamine-induced behavior and neuropeptide gene expression in the striatum. Neuroscience (2006) 1.02
Detection of dopaminergic cell loss and neural transplantation using pharmacological MRI, PET and behavioral assessment. Neuroreport (1999) 1.01
Hypoinsulinemia may mediate the lowering of self-stimulation thresholds by food restriction and streptozotocin-induced diabetes. Brain Res (2000) 1.00
Dopamine D2 receptor regulation of the dopamine transporter expressed in Xenopus laevis oocytes is voltage-independent. Mol Pharmacol (2001) 0.98
CaMKII regulates amphetamine-induced ERK1/2 phosphorylation in striatal neurons. Neuroreport (2002) 0.98
Insulin replacement restores the behavioral effects of quinpirole and raclopride in streptozotocin-treated rats. J Pharmacol Exp Ther (2006) 0.97
Neuronal signaling systems and ethanol dependence. Mol Neurobiol (1998) 0.95
CB1-independent inhibition of dopamine transporter activity by cannabinoids in mouse dorsal striatum. J Neurochem (2007) 0.95
Amphetamine levels in brain microdialysate, caudate/putamen, substantia nigra and plasma after dosage that produces either behavioral or neurotoxic effects. J Pharmacol Exp Ther (1995) 0.93
Differences in the in vivo dynamics of neurotransmitter release and serotonin uptake after acute para-methoxyamphetamine and 3,4-methylenedioxymethamphetamine revealed by chronoamperometry. Neurochem Int (2005) 0.91
Metabolism of amphetamine after acute and chronic administration to the rat. J Pharmacol Exp Ther (1978) 0.89
Changes in the central dopaminergic systems in the streptozotocin-induced diabetic rats. Arch Pharm Res (1994) 0.89
Dopamine receptor binding is increased in diabetic rats. Science (1981) 0.88
Evidence for D2 receptor mediation of amphetamine-induced normalization of locomotion and dopamine transporter function in hypoinsulinemic rats. J Neurochem (2007) 0.87
Insulin regulation of monoamine signaling: pathway to obesity. Neuropsychopharmacology (2011) 0.87
Protein kinase A activity may kinetically upregulate the striatal transporter for dopamine. J Neurosci (1998) 0.86
Relationship among hyperinsulinemia, insulin resistance, and hypertension is dependent on sex. Am J Physiol Heart Circ Physiol (2002) 0.86
Decreased brain dopamine synthesis rate and increased [3H]spiroperidol binding in streptozotocin-diabetic rats. J Neurochem (1983) 0.85
Diabetes decreases limbic extracellular dopamine in rats. Neurosci Lett (1996) 0.85
Chronic exposure to manganese alters brain responses to amphetamine: a pharmacological magnetic resonance imaging study. Toxicol Sci (2010) 0.80
Effects of alloxan-induced diabetes on dopaminergic receptors in rat striatum and anterior pituitary. Horm Res (1985) 0.79
Effects of intermittent and continuous subchronic administration of raclopride on motor activity, dopamine turnover and receptor occupancy in the rat. Pharmacol Toxicol (1996) 0.78
Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol (2005) 5.13
Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport. Neuron (2006) 2.00
Amphetamine induces dopamine efflux through a dopamine transporter channel. Proc Natl Acad Sci U S A (2005) 1.98
N-terminal phosphorylation of the dopamine transporter is required for amphetamine-induced efflux. PLoS Biol (2004) 1.94
Amphetamine-induced dopamine efflux. A voltage-sensitive and intracellular Na+-dependent mechanism. J Biol Chem (2003) 1.69
PI 3-kinase regulation of dopamine uptake. J Neurochem (2002) 1.64
Mitogen-activated protein kinase regulates dopamine transporter surface expression and dopamine transport capacity. J Neurosci (2003) 1.63
A practical guide to robust detection of GABA in human brain by J-difference spectroscopy at 3 T using a standard volume coil. Magn Reson Imaging (2007) 1.49
Cocaine increases dopamine uptake and cell surface expression of dopamine transporters. Biochem Biophys Res Commun (2002) 1.49
Hypoinsulinemia regulates amphetamine-induced reverse transport of dopamine. PLoS Biol (2007) 1.48
Autism gene variant causes hyperserotonemia, serotonin receptor hypersensitivity, social impairment and repetitive behavior. Proc Natl Acad Sci U S A (2012) 1.48
High-resolution 7T MRI of the human hippocampus in vivo. J Magn Reson Imaging (2008) 1.46
Flotillin-1 is essential for PKC-triggered endocytosis and membrane microdomain localization of DAT. Nat Neurosci (2011) 1.41
Anomalous dopamine release associated with a human dopamine transporter coding variant. J Neurosci (2008) 1.41
Syntaxin 1A interaction with the dopamine transporter promotes amphetamine-induced dopamine efflux. Mol Pharmacol (2008) 1.38
Regulation of dopamine transporter function and plasma membrane expression by dopamine, amphetamine, and cocaine. Eur J Pharmacol (2003) 1.38
A regulated interaction of syntaxin 1A with the antidepressant-sensitive norepinephrine transporter establishes catecholamine clearance capacity. J Neurosci (2003) 1.35
Deficits in dopamine clearance and locomotion in hypoinsulinemic rats unmask novel modulation of dopamine transporters by amphetamine. J Neurochem (2005) 1.34
Decynium-22 enhances SSRI-induced antidepressant-like effects in mice: uncovering novel targets to treat depression. J Neurosci (2013) 1.29
Organic cation transporter 3: Keeping the brake on extracellular serotonin in serotonin-transporter-deficient mice. Proc Natl Acad Sci U S A (2008) 1.29
Amphetamine regulation of dopamine transport. Combined measurements of transporter currents and transporter imaging support the endocytosis of an active carrier. J Biol Chem (2003) 1.29
High-resolution maps of real and illusory tactile activation in primary somatosensory cortex in individual monkeys with functional magnetic resonance imaging and optical imaging. J Neurosci (2007) 1.26
Insulin reveals Akt signaling as a novel regulator of norepinephrine transporter trafficking and norepinephrine homeostasis. J Neurosci (2010) 1.25
Density and function of central serotonin (5-HT) transporters, 5-HT1A and 5-HT2A receptors, and effects of their targeting on BTBR T+tf/J mouse social behavior. J Neurochem (2010) 1.24
The HIV Dementia Scale: predictive power in mild dementia and HAART. J Neurol Sci (2007) 1.23
Regulation of dopamine transporter trafficking by intracellular amphetamine. Mol Pharmacol (2006) 1.22
Interleukin-1 receptor activation by systemic lipopolysaccharide induces behavioral despair linked to MAPK regulation of CNS serotonin transporters. Neuropsychopharmacology (2010) 1.22
Role for mTOR signaling and neuronal activity in morphine-induced adaptations in ventral tegmental area dopamine neurons. Neuron (2011) 1.21
Biogenic amine neurotransmitter transporters: just when you thought you knew them. Physiology (Bethesda) (2005) 1.20
Dysregulation of dopamine transporters via dopamine D2 autoreceptors triggers anomalous dopamine efflux associated with attention-deficit hyperactivity disorder. J Neurosci (2010) 1.19
Ethanol-related behaviors in serotonin transporter knockout mice. Alcohol Clin Exp Res (2006) 1.18
Feeding conditions differentially affect the neurochemical and behavioral effects of dopaminergic drugs in male rats. Eur J Pharmacol (2008) 1.18
Currents in response to rapid concentration jumps of amphetamine uncover novel aspects of human dopamine transporter function. J Neurosci (2008) 1.17
Intracellular Ca2+ regulates amphetamine-induced dopamine efflux and currents mediated by the human dopamine transporter. Mol Pharmacol (2004) 1.16
Dysregulation of the norepinephrine transporter sustains cortical hypodopaminergia and schizophrenia-like behaviors in neuronal rictor null mice. PLoS Biol (2010) 1.16
Attention deficit/hyperactivity disorder-derived coding variation in the dopamine transporter disrupts microdomain targeting and trafficking regulation. J Neurosci (2012) 1.14
A juxtamembrane mutation in the N terminus of the dopamine transporter induces preference for an inward-facing conformation. Mol Pharmacol (2008) 1.13
Parameterization-invariant shape comparisons of anatomical surfaces. IEEE Trans Med Imaging (2010) 1.12
Exendin-4 decreases amphetamine-induced locomotor activity. Physiol Behav (2012) 1.09
Exaggerated effect of fluvoxamine in heterozygote serotonin transporter knockout mice. J Neurochem (2003) 1.07
Amphetamine induces a calcium/calmodulin-dependent protein kinase II-dependent reduction in norepinephrine transporter surface expression linked to changes in syntaxin 1A/transporter complexes. Mol Pharmacol (2006) 1.06
You are what you eat: influence of type and amount of food consumed on central dopamine systems and the behavioral effects of direct- and indirect-acting dopamine receptor agonists. Neuropharmacology (2012) 1.04
Molecular mechanisms of amphetamine actions in Caenorhabditis elegans. Mol Pharmacol (2010) 1.04
Insulin signaling and addiction. Neuropharmacology (2011) 1.04
Transgenic elimination of high-affinity antidepressant and cocaine sensitivity in the presynaptic serotonin transporter. Proc Natl Acad Sci U S A (2011) 1.03
Repeated swim impairs serotonin clearance via a corticosterone-sensitive mechanism: organic cation transporter 3, the smoking gun. J Neurosci (2010) 1.02
Measuring brain manganese and iron accumulation in rats following 14 weeks of low-dose manganese treatment using atomic absorption spectroscopy and magnetic resonance imaging. Toxicol Sci (2008) 1.02
Impaired striatal Akt signaling disrupts dopamine homeostasis and increases feeding. PLoS One (2011) 1.01
Calcium-dependent inhibition of synaptosomal serotonin transport by the alpha 2-adrenoceptor agonist 5-bromo-N-[4,5-dihydro-1H-imidazol-2-yl]-6-quinoxalinamine (UK14304). J Pharmacol Exp Ther (2003) 1.00
2D arbitrary shape-selective excitation summed spectroscopy (ASSESS). Magn Reson Med (2007) 1.00
An event-related potential study of response inhibition in ADHD with and without prenatal alcohol exposure. Alcohol Clin Exp Res (2010) 1.00
Subcellular localization of the antidepressant-sensitive norepinephrine transporter. BMC Neurosci (2009) 1.00
Amphetamine actions at the serotonin transporter rely on the availability of phosphatidylinositol-4,5-bisphosphate. Proc Natl Acad Sci U S A (2013) 0.99
Validation of DTI tractography-based measures of primary motor area connectivity in the squirrel monkey brain. PLoS One (2013) 0.98
Imaging body composition in obesity and weight loss: challenges and opportunities. Diabetes Metab Syndr Obes (2010) 0.98
Rapid stimulation of presynaptic serotonin transport by A(3) adenosine receptors. J Pharmacol Exp Ther (2007) 0.97
Insulin replacement restores the behavioral effects of quinpirole and raclopride in streptozotocin-treated rats. J Pharmacol Exp Ther (2006) 0.97
PI3K signaling supports amphetamine-induced dopamine efflux. Biochem Biophys Res Commun (2008) 0.97
Selective decreases in amphetamine self-administration and regulation of dopamine transporter function in diabetic rats. Neuroendocrinology (2003) 0.96
5-Hydroxytryptamine2C receptor contribution to m-chlorophenylpiperazine and N-methyl-beta-carboline-3-carboxamide-induced anxiety-like behavior and limbic brain activation. J Pharmacol Exp Ther (2006) 0.96
CB1-independent inhibition of dopamine transporter activity by cannabinoids in mouse dorsal striatum. J Neurochem (2007) 0.95
Amide proton transfer imaging of the human breast at 7T: development and reproducibility. NMR Biomed (2013) 0.94
Automated segmentation of multispectral brain MR images. J Neurosci Methods (2002) 0.94
Cerulein-induced acute pancreatitis in the rat is significantly ameliorated by treatment with MEK1/2 inhibitors U0126 and PD98059. Pancreas (2002) 0.93
Dopamine transport currents are promoted from curiosity to physiology. Trends Neurosci (2003) 0.93
Both TMEM16F-dependent and TMEM16F-independent pathways contribute to phosphatidylserine exposure in platelet apoptosis and platelet activation. Blood (2013) 0.93
Functional magnetic resonance imaging of awake monkeys: some approaches for improving imaging quality. Magn Reson Imaging (2011) 0.93
Dependence of BOLD signal change on tactile stimulus intensity in SI of primates. Magn Reson Imaging (2007) 0.92
Comparison of gross body fat-water magnetic resonance imaging at 3 Tesla to dual-energy X-ray absorptiometry in obese women. Obesity (Silver Spring) (2013) 0.92
Missense dopamine transporter mutations associate with adult parkinsonism and ADHD. J Clin Invest (2014) 0.92
Changes in dietary iron exacerbate regional brain manganese accumulation as determined by magnetic resonance imaging. Toxicol Sci (2010) 0.92
Rab11 supports amphetamine-stimulated norepinephrine transporter trafficking. J Neurosci (2010) 0.91
Differences in the in vivo dynamics of neurotransmitter release and serotonin uptake after acute para-methoxyamphetamine and 3,4-methylenedioxymethamphetamine revealed by chronoamperometry. Neurochem Int (2005) 0.91
Anterior cingulate and cerebellar GABA and Glu correlations measured by ¹H J-difference spectroscopy. Magn Reson Imaging (2010) 0.91
Prenatal alcohol exposure and interhemispheric transfer of tactile information: Detroit and Cape Town findings. Alcohol Clin Exp Res (2009) 0.90
A model for the analysis of competitive relaxation effects of manganese and iron in vivo. NMR Biomed (2009) 0.90
Molecular imaging without radiopharmaceuticals? J Nucl Med (2009) 0.90
Failure to direct detect magnetic field dephasing corresponding to ERP generation. Magn Reson Imaging (2008) 0.90
Dynamic B0 shimming at 7 T. Magn Reson Imaging (2011) 0.88
Evidence for D2 receptor mediation of amphetamine-induced normalization of locomotion and dopamine transporter function in hypoinsulinemic rats. J Neurochem (2007) 0.87
Insulin regulation of monoamine signaling: pathway to obesity. Neuropsychopharmacology (2011) 0.87